369
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The Association of Serum Lipid Levels with Breast Cancer Risks Among Women with Breast Cancer at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia

, ORCID Icon & ORCID Icon
Pages 279-287 | Published online: 14 Dec 2020

References

  • DentonM. Breast Cancer: Risks, Detection, and Treatment. Greenhaven Publishing LLC; 2017.
  • CalhounKE, AndersonBO. Lobular Carcinoma in situ of the Breast. The Breast. Elsevier; 2018:553–61. e2.
  • MakamaM, DrukkerC, RutgersET, et al. An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®). Eur J Cancer. 2017;75:5–13. doi:10.1016/j.ejca.2016.12.02428214658
  • YooKY, KangD, ParkSK, et al. Epidemiology of breast cancer in Korea: occurrence, high-risk groups, and prevention. J Korean Med Sci. 2002;17(1):1. doi:10.3346/jkms.2002.17.1.111850580
  • Sousa-e-SilvaÉ, CondeDM, Costa-PaivaL, MartinezEZ, Pinto-NetoAM. Cardiovascular risk in middle-aged breast cancer survivors: a comparison between two risk models. Rev Bras Ginecol Obstet. 2014;36(4):157–162. doi:10.1590/S0100-720320140050.000224675977
  • PaleyPJ. Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol. 2001;184(5):1021–1030. doi:10.1067/mob.2001.11171411303215
  • BrayF, FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.30207593
  • SingletarySE. Rating the risk factors for breast cancer. Ann Surg. 2003;237(4):474. doi:10.1097/01.SLA.0000059969.64262.8712677142
  • RahimzadehM, BaghestaniAR, GohariMR, PourhoseingholiMA. Estimation of the cure rate in Iranian breast cancer patients. Asian Pac J Cancer Prev. 2014;15(12):4839–4842. doi:10.7314/APJCP.2014.15.12.483924998549
  • FerlayJ, ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. doi:10.1002/ijc.2551621351269
  • CondeD, Costa-PaivaL, MartinezE, Pinto-NetoA. Cardiovascular risk in middle-aged breast cancer survivors: a comparison between two risk models [risco Cardiovascular Em Mulheres De Meia-idade Com Câncer De Mama: uma Comparação Entre Dois Modelos De Risco]. Rev Bras Ginecol Obstet. 2014.
  • KnappML, Al-SheibaniS, RichesPG. Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors. Clin Chem. 1991;37(12):2093–2101. doi:10.1093/clinchem/37.12.20931764785
  • MariamMBB, DeviD. The prevalence of dyslipidemia among postmenopausal women in Bangalore (urban area). Int J Emerg Trends Sci Technol. 2016;3(3):3718–3724.
  • LingwoodD, SimonsK. Lipid rafts as a membrane-organizing principle. Science. 2010;327(5961):46–50. doi:10.1126/science.117462120044567
  • MenendezJA, LupuR. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763–777. doi:10.1038/nrc222217882277
  • CedóL, ReddyST, MatoE, Blanco-VacaF, Escolà-GilJC. HDL and LDL: potential new players in breast cancer development. J Clin Med. 2019;8(6):853. doi:10.3390/jcm8060853
  • DagmaweNIn depth investigation of relationship between index property and swelling characteristic of expansive soil in Bahir Dar [Unpublished MSC Thesis]. Eurohazcon Collaboration Addis Ababa University2007.
  • PeelaJ, JarariA, El SaietyS, El BusaifiS, SrikumarS. The relationship between serum lipids and breast cancer in Libya. Biochem Anal Biochem. 2012;1(6):1–3. doi:10.4172/2161-1009.1000117
  • KhaderYS, BatiehaA, El-KhateebM, Al OmariM, AjlouniK. Prevalence of dyslipidemia and its associated factors among jordanian adults. J Clin Lipidol. 2010;4(1):53–58. doi:10.1016/j.jacl.2009.12.00421122627
  • Organization WH. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. Vol. 8–11Geneva: 12, 2008:2011.
  • PandeyaDR, RajbhandariA, NepalM, et al. Comparative study of serum lipid profiles in nepalese cancer patients attending a Tertiary Care Hospital. Asian Pac J Cancer Prev. 2018;19(2):491.29480987
  • CoatesA, AhernT, BorgquistS, ColleoniM, DebledM, EjlertsenB, editors. Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1–98 study. Am Soc Clin Oncol. 2017;35(11):1179–1188
  • SinagraD, AmatoC, ScarpittaA, et al. Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci. 2002;6:55–59.12708611
  • LiX, LiuZ-L, WuY-T, et al. Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy. Lipids Health Dis. 2018;17(1):91. doi:10.1186/s12944-018-0745-129678178
  • ChangS-J, HouM-F, TsaiS-M, et al. The association between lipid profiles and breast cancer among Taiwanese women. Clin Chem Lab Med. 2007;45(9):1219–1223. doi:10.1515/CCLM.2007.26317663634
  • AbdAA. Assessment of lipid profile parameters in women with benign and malignant breast tumor. Muthanna Med J. 2019;6(1):13–25.
  • KachhawaP, KachhawaK, AgrawalD, SinhaV, SarkarPD, KumarS. Association of dyslipidemia, increased insulin resistance, and serum CA 15-3 with increased risk of breast cancer in urban areas of North and Central India. J Midlife Health. 2018;9(2):85. doi:10.4103/jmh.JMH_77_1729962807
  • AkalankaH, EkanayakeS, SamarasingheK. Could anthropometric and lipid parameters reflect susceptibility to breast Cancer? Comparison of newly diagnosed breast cancer and apparently healthy women. Asian Pac J Cancer Prev. 2018;19(9):2475.30255702
  • NelsonER, ChangC-Y, McDonnellDP. Cholesterol and breast cancer pathophysiology. Trends Endocrinol Metab. 2014;25(12):649–655. doi:10.1016/j.tem.2014.10.00125458418
  • ShahFD, ShuklaSN, ShahPM, PatelHR, PatelPS. Significance of alterations in plasma lipid profile levels in breast cancer. Integr Cancer Ther. 2008;7(1):33–41. doi:10.1177/153473540731388318292593
  • LaamiriFZ, OtmaniA, AhidS, BarkatA. Lipid profile among moroccan overweight women and breast cancer: a case-control study. Int J Gen Med. 2013;6:439.23785239
  • JohnsonKE, SiewertKM, KlarinD, et al. The relationship between circulating lipids and breast cancer risk: a mendelian randomization study. PLoS Med. 2020;17(9):e1003302. doi:10.1371/journal32915777
  • KimY, ParkSK, HanW, et al. Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiol Prev Biomarkers. 2009;18(2):508–515. doi:10.1158/1055-9965.EPI-08-0133
  • BadeG, ShahS, NaharP, VaidyaS. Effect of menopause on lipid profile in relation to body mass index. Chron Young Sci. 2014;5(1):20. doi:10.4103/2229-5186.129331
  • FranssenR, MonajemiH, StroesES, KasteleinJJ. Obesity and dyslipidemia. Med Clin North Am. 2011;95(5):893–902. doi:10.1016/j.mcna.2011.06.00321855698
  • YangouaHCM, AzantsaBGK, KuateD, et al. Characterization of dyslipidemia and assessment of atherogenic risk amongst cameroonian living in yaounde: a Cross Sectional Study. J Biosci Med. 2019;7(7):35–50. doi:10.4236/jbm.2019.77004
  • HisM, DartoisL, FagherazziG, et al. Associations between serum lipids and breast cancer incidence and survival in the E3N prospective cohort study. Cancer Causes Control. 2017;28(1):77–88.27864712
  • MelvinJC, SethD, HolmbergL, et al. Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Prev Biomarkers. 2012;21(8):1381–1384. doi:10.1158/1055-9965.EPI-12-0188